Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Eurofins Biopharma Product Testing Sweden AB

Closing information (x1000 NOK)

Closing information 2023/12 2022/12 2021/12
Turnover 68,388 Less Arrow 58,424 Less Arrow 54,726
Financial expenses 2,626 Less Arrow 1,584 Less Arrow 1,128
Earnings before taxes -20,640 More Arrow -19,885 Less Arrow -22,594
EBITDA -13,109 Less Arrow -13,566 Less Arrow -16,474
Total assets 37,121 More Arrow 43,662 More Arrow 59,805
Current assets 21,331 More Arrow 24,608 More Arrow 41,163
Current liabilities 22,100 Less Arrow 13,137 More Arrow 13,592
Equity capital -18,911 More Arrow 1,578 More Arrow 18,100
- share capital 101 Less Arrow 95 More Arrow 98
Employees (average) 46 More Arrow 50 More Arrow 60

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency -50.9% More Arrow 3.6% More Arrow 30.3%
Turnover per employee 1,487 Less Arrow 1,168 Less Arrow 912
Profit as a percentage of turnover -30.2% Less Arrow -34.0% Less Arrow -41.3%
Return on assets (ROA) -48.5% More Arrow -41.9% More Arrow -35.9%
Current ratio 96.5% More Arrow 187.3% More Arrow 302.8%
Return on equity (ROE) 109.1% Less Arrow -1260.1% More Arrow -124.8%
Change turnover 5,818 Less Arrow 5,343 Less Arrow -4,536
Change turnover % 9% More Arrow 10% Less Arrow -8%
Chg. No. of employees -4 Less Arrow -10 More Arrow 8
Chg. No. of employees % -8% Less Arrow -17% More Arrow 15%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.